Accretive Wealth Partners Portfolio holdings
Top Buys
| 1 |
Vanguard Value ETF
VTV
|
+$2.83M |
| 2 |
Dimensional US High Profitability ETF
DUHP
|
+$1.77M |
| 3 |
Colgate-Palmolive
CL
|
+$1.62M |
| 4 |
Capital Group Core Bond ETF
CGCB
|
+$1.38M |
| 5 |
JPMorgan Limited Duration Bond ETF
JPLD
|
+$1.3M |
Top Sells
| 1 |
NVO
Novo Nordisk
NVO
|
+$257K |
| 2 |
General Mills
GIS
|
+$220K |
| 3 |
Global X FinTech ETF
FINX
|
+$212K |
| 4 |
IQVIA
IQV
|
+$208K |
| 5 |
iShares Silver Trust
SLV
|
+$159K |
Sector Composition
| 1 | Technology | 9.51% |
| 2 | Financials | 6.36% |
| 3 | Industrials | 5.11% |
| 4 | Consumer Discretionary | 5.07% |
| 5 | Consumer Staples | 4.61% |
Similar funds
Accretive Wealth Partners's Q1 2026 Portfolio in Review
As of Q1 2026, Accretive Wealth Partners held 184 positions worth $356M, up 5.6% from $337M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Accretive Wealth Partners deployed $28.6M of net new capital in Q1 2026, opening 31 new positions and adding to 100 existing holdings. Its largest new stake was Dimensional US High Profitability ETF: 46,158 shares worth $1.7M.
By sector, the portfolio is most concentrated in Technology at 9.5% of assets, down from 12% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was iShares Silver Trust, an estimated $159K trimmed.
- Accretive Wealth Partners's largest Q1 2026 buy was Dimensional US High Profitability ETF: 46,158 shares worth $1.7M.
- Accretive Wealth Partners added most to Vanguard Value ETF in Q1 2026, an estimated $2.83M increase.
- Accretive Wealth Partners's biggest Q1 2026 reduction was iShares Silver Trust, cutting an estimated $159K.
- Accretive Wealth Partners fully exited Novo Nordisk in Q1 2026, selling an estimated $257K.
- Accretive Wealth Partners's ten largest holdings make up 36% of its $356M portfolio in Q1 2026.
- Accretive Wealth Partners opened 31 new positions and closed 4 in Q1 2026.
- Accretive Wealth Partners's portfolio value rose 5.6% quarter-over-quarter to $356M.
Based on Accretive Wealth Partners's 13F filing for Q1 2026, filed 22 Apr 2026.